Clinical Trials
73
Active:1
Completed:49
Trial Phases
5 Phases
Phase 1:2
Phase 2:5
Phase 3:2
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (39 trials with phase data)• Click on a phase to view related trials
Not Applicable
26 (66.7%)Phase 2
5 (12.8%)Phase 4
4 (10.3%)Phase 1
2 (5.1%)Phase 3
2 (5.1%)Prediction of Postoperative Outcomes After Rectal Resection by the Comprehensive Complication Index (CCI)
Completed
- Conditions
- Rectal Diseases
- First Posted Date
- 2025-06-25
- Last Posted Date
- 2025-06-25
- Lead Sponsor
- Cantonal Hospital of St. Gallen
- Target Recruit Count
- 958
- Registration Number
- NCT07037693
- Locations
- 🇨🇭
HOCH Health Ostschweiz, Kantonsspital St.Gallen, St.Gallen, Switzerland
Influence of Hospital Volume on Mortality and Short-term Postoperative Outcomes in Uncomplex General Surgery in Switzerland
Completed
- Conditions
- CholecystolithiasisFemoral HerniaUmbilical HerniaAppendicitisCholecystitisInguinal Hernia
- First Posted Date
- 2025-06-15
- Last Posted Date
- 2025-06-15
- Lead Sponsor
- Cantonal Hospital of St. Gallen
- Target Recruit Count
- 399701
- Registration Number
- NCT07022665
- Locations
- 🇨🇭
HOCH Health Ostschweiz, Kantonsspital St.Gallen, St.Gallen, Switzerland
Influence of Hospital Volume on Mortality and Length of Hospital Stay After Pancreatic Resection in Switzerland
Completed
- Conditions
- Pancreatic Diseases
- First Posted Date
- 2025-06-15
- Last Posted Date
- 2025-07-10
- Lead Sponsor
- Cantonal Hospital of St. Gallen
- Target Recruit Count
- 6785
- Registration Number
- NCT07022639
- Locations
- 🇨🇭
HOCH Health Ostschweiz, Kantonsspital St.Gallen, St.Gallen, Switzerland
Influence of Hospital Volume on Mortality and Length of Hospital Stay After Oesophageal Cancer Resection in Switzerland
Completed
- Conditions
- Esophageal Cancer
- First Posted Date
- 2025-06-15
- Last Posted Date
- 2025-06-15
- Lead Sponsor
- Cantonal Hospital of St. Gallen
- Target Recruit Count
- 2880
- Registration Number
- NCT07022652
- Locations
- 🇨🇭
HOCH Health Ostschweiz, Kantonsspital St.Gallen, St.Gallen, Switzerland
Nevirapine / Lamivudine for HIV Maintenance Therapy
Phase 4
Completed
- Conditions
- HIV InfectionMaintenance TherapyAntiretroviral Treatment
- Interventions
- Drug: Neviparine (NVP)/ Lamivudine (3TC)
- First Posted Date
- 2025-06-10
- Last Posted Date
- 2025-06-10
- Lead Sponsor
- Cantonal Hospital of St. Gallen
- Target Recruit Count
- 201
- Registration Number
- NCT07014189
- Locations
- 🇨🇭
Cantonal Hospital St. Gallen, St. Gallen, Switzerland
- Prev
- 1
- 2
- 3
- 4
- 5
- 15
- Next
News
No news found